We are monitoring the impact of COVID-19 & Recession alarm on North America Antibodies Market Get in touch with us for detailed analysis Know More
Share on

North America Antibodies Market Research Report – Segmented By Product Type, Indication, End User, Application & By Country (U.S., Canada & Rest of North America) - Industry Analysis on Size, Share, Trends, COVID-19 Impact & Growth Forecast (2022 to 2027)

Published: January, 2022
ID: 1113
Pages: 145

North America Antibodies Market Size (2022 to 2027)

The size of the North America Antibodies Market was valued at USD 63.55 Billion in 2022 and estimated to reach USD 114.26 Billion by the end of 2027, growing at a CAGR of 12.45 % during the forecast period.

The market for antibodies in North America is majorly driven by continuous development of innovative products, increased adoption rate to therapeutic antibodies in cost-sensitive markets, rise in chronic illnesses owing to population shift and rising longevity, rapid approval by regulatory authorities for breakthrough therapies, and adoption of diagnostic antibodies. Companies are adopting various strategies, like the expansion of product indications to sustain the dynamically growing market.

The antibodies market is a very fast-growing market in terms of research, and there is constant innovation in the field. Constant innovation of newer innovative products is therefore known to drive the demand in the market. Also, very cost-sensitive markets are now adapting to the therapeutic antibodies, increasing the demand for the antibodies.

The epidemiological transition from acute to chronic illnesses and increased life expectancy in North America has increased the demand for antibodies in the long run. The fertile environment for the new therapeutic antibodies, government policies are further helping the industry to flourish. The companies adapt to the changing market and orient their business plan and policies to help increase the antibodies sector.

The high cost of treatment and side effects associated with antibody treatment are the restraints that affect the market's growth.

Impact of COVID-19 on the North American antibodies market:

The COVID-19 epidemic has offered significant business prospects. Several pharmaceuticals are doing considerable R&D to create innovative vaccinations, treatment methods, and diagnostic kits for this pandemic. The need for research antibodies has risen considerably due to these intensive R&D operations to develop innovative vaccination and therapy methods. Moreover, several corporate and public entities are taking significant steps to assist the development of COVID-19 vaccines and treatments. As a result, the worldwide antibody market was extremely beneficial due to the vast range of applications for which it may be used.

This research report on the North American antibodies market has been segmented and sub-segmented into the following categories:

By Product Type:

  • Monoclonal Antibodies
    • Murine
    • Chimeric
    • Humanized
    • Human
  • Polyclonal Antibodies
    • Type I
    • Type II
    • Type III
    • Type IV
    • Type V
    • Type VI
    • Type VII
    • Type VIII
  • Anti-body drug complexes
    • Immunogen Technology
    • Seattle Genetics Technology
    • Immunomedics Technology

By Indication:

  • Cancer
  • Autoimmune Diseases
  • Infectious Diseases
  • Cardiovascular Diseases
  • CNS Disorders
  • Others (Inflammatory, Microbial Diseases, & Other)

By End User:

  • Hospitals/Clinics
  • Research institute
  • Diagnostics laboratories

By Application:

  • Medical
  • Experimental
  • Western blot
  • ELISA
  • Radioimmune Assays
  • Immunofluorescence
  • Others (Immunohistochemistry, Immunoprecipitation, & Immunocytochemistry)

By Country:

  • The United States
  • Canada
  • Rest of North America

Geographically, in 2020, North America dominated the global antibodies market with a share of 39.7%. This is due to increased research in the domains of proteomics and genomics and the existence of major biopharmaceutical and biotechnology companies.

The market in North America is growing because of the rising incidence of cardiovascular disease, increased need for antibodies for research reproductivity, government investments in improving healthcare expenses, and increased development efforts to create better diagnostic therapy. Investing in medicines and improving healthcare infrastructure

These antibodies can be used to develop medicinal therapies and test immunoassays. Immunoassay tests are used to determine if a certain antigen or antibody is present in a patient's blood or other fluid samples. It's frequently utilized in novel drug development, drug monitoring, and food sample testing.

The Canadian antibodies market is also estimated to increase its market growth in the upcoming years with the government's help.

KEY MARKET PLAYERS:

A few promising companies in the North American antibodies market profiled in the report are Abbott Diagnostics, Novartis AG, Pfizer Inc., Thermo Fisher Scientific Inc., Eli Lilly and company, A.G. Scientific, Inc., Bristol-Myers Squibb, F. Hoffmann-La Roche Ltd, and AbbVie Inc.

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                           

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                              

                2.2 Research Phases                      

                                2.2.1 Secondary Research            

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling     

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                      

                3.1 Executive Summary                

                3.2 Key Inferences                         

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                      

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market               

5. Market Segmentation                                              

                5.1 By Product Type                       

                                5.1.1 Monoclonal Antibodies     

                                                5.1.1.1 Murine

                                                5.1.1.2 Chimeric

                                                5.1.1.3 Humanized

                                                5.1.1.4 Human 

                                5.1.2 Polyclonal Antibodies         

                                                5.1.2.1 Type I

                                                5.1.2.2 Type II

                                                5.1.2.3 Type III

                                                5.1.2.4 Type IV

                                                5.1.2.5 Type V

                                                5.1.2.6 Type VI

                                                5.1.2.7 Type VII

                                                5.1.2.8 Type VIII

                                5.1.3 Antibody-Drug Complexes

                                                5.1.3.1 Immunogen Technology

                                                5.1.3.2 Seattle Genetics Technology

                                                5.1.3.3 Immunomedics Technology

                5.2 By Indication                              

                                5.2.1 Cancer      

                                5.2.2 Autoimmune Diseases       

                                5.2.3 Infectious Diseases             

                                5.2.4 Cardiovascular Diseases    

                                5.2.5 CNS Disorders       

                                5.2.6 Others (Inflammatory, Microbial Diseases, & Other)             

                5.3 End User                     

                                5.3.1 Hospitals/Clinics   

                                5.3.2 Research Institute

                                5.3.3 Diagnostic Laboratories     

                5.4 Application                 

                                5.4.1 Medical    

                                5.4.2 Experimental         

                                                5.4.2.1 Western Blot

                                                5.4.2.2 ELISA

                                                5.4.2.3 Radioimmune Assays 

                                                5.4.2.4 Immunofluorescence 

                                                5.4.2.5 Other (Immunohistochemistry, Immunoprecipitation, & Immunocytochemistry)

6. Geographical Analysis                                              

                6.1 North America                          

                                6.1.1 Introduction           

                                6.1.2 United States         

                                6.1.3 Canada     

7. Pipeline Product Analysis                                        

                7.1 Overview                    

                7.2 Pipeline Development Landscape                     

                7.3 Molecular Targets in the Pipeline                      

                7.4 Clinical Trials                              

                                7.4.1 Failure Rate by Stage of Development, Indication, Molecule Type and Molecular Target       

                                7.4.2 Clinical Trial Duration by Stage of Development, Indication, Molecule Type and Molecular Target                

                                7.4.3 Clinical Trial Size by Stage of Development, Indication, Molecule Type and Molecular Target               

                7.5 Key Trends in Antibodies Development                         

                                7.5.1 Targeted Therapies             

                7.6 Promising Antibodies in Pipeline                       

                7.7 Heat Map of Safety and Efficacy for Pipeline and Marketed Antibodies                            

8.Strategic Analysis                                        

                8.1 PESTLE analysis                         

                                8.1.1 Political     

                                8.1.2 Economic 

                                8.1.3 Social         

                                8.1.4 Technological         

                                8.1.5 Legal          

                                8.1.6 Environmental      

                8.2 Porter’s Five analysis                              

                                8.2.1 Bargaining Power of Suppliers        

                                8.2.2 Bargaining Power of Consumers    

                                8.2.3 Threat of New Entrants     

                                8.2.4 Threat of Substitute Products and Services

                                8.2.5 Competitive Rivalry within the Industry      

9.Market Leaders' Analysis                                          

                9.1 Abbott Diagnostics (US)                        

                                9.1.1 Overview

                                9.1.2 Product Analysis   

                                9.1.3 Financial analysis  

                                9.1.4 Recent Developments       

                                9.1.5 SWOT analysis       

                                9.1.6 Analyst View          

                9.2 Novartis AG (Switzerland)                    

                9.3 Pfizer Inc. (U.S.)                       

                9.4 Thermo Fisher Scientific Inc. (U.S.)                   

                9.5 Eli Lilly and Company (U.S.)                 

                9.6 A.G. Scientific, Inc. (U.S.)                      

                9.7 Bristol-Myers Squibb (U.S.)                 

                9.9 F. Hoffmann-La Roche Ltd. (Switzerland)                       

                9.10 AbbVie Inc. (U.S.)                  

10.Competitive Landscape                                          

                10.1 Market share analysis                          

                10.2 Merger and Acquisition Analysis                     

                10.3 Agreements, collaborations and Joint Ventures                       

                10.4 New Product Launches                       

11.Expert Opinions                                         

                11.1 Market Outlook                     

                11.2 Investment Opportunities                 

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  1. North America Antibodies Market, By Product type, From 2022 - 2027 (USD Million)
  2. North America Monoclonal Antibodies Market, By Region, From 2022 - 2027 (USD Million)
  3. North America Polyclonal Antibodies Market, By Region, From 2022 - 2027 (USD Million)
  4. North America Antibody-Drug complexes Market, By Region, From 2022 - 2027 (USD Million)
  5. North America Antibodies Market, By Indication, From 2022 - 2027 (USD Million)
  6. North America Cancer Market, By Region, From 2022 - 2027 (USD Million)
  7. North America Auto immune diseases Market, By Region, From 2022 - 2027 (USD Million)
  8. North America infectious diseases Market, By Region, From 2022 - 2027 (USD Million)
  9. North America Cardiovascular diseases Market, By Region, From 2022 - 2027 (USD Million)
  10. North America CNS disorders Market, By Region, From 2022 - 2027 (USD Million)
  11. North America Antibodies Market, By End users, From 2022 - 2027 (USD Million)
  12. North America Hospitals Market, By Region, From 2022 - 2027 (USD Million)
  13. North America Research institute Market, By Region, From 2022 - 2027 (USD Million)
  14. North America Diagnostics laboratories Market, By Region, From 2022 - 2027 (USD Million)
  15. North America Antibodies Market, By Application, From 2022 - 2027 (USD Million)
  16. North America Medical Market, By Region, From 2022 - 2027 (USD Million)
  17. North America Experimental Market, By Region, From 2022 - 2027 (USD Million)
  18. United States Antibodies Market, By Product type, From 2022 - 2027 (USD Million)
  19. United States Antibodies Market, By Indication, From 2022 - 2027 (USD Million)
  20. United States Antibodies Market, By End users, From 2022 - 2027 (USD Million)
  21. United States Antibodies Market, By Application, From 2022 - 2027 (USD Million)
  22. Canada Antibodies Market, By Product type, From 2022 - 2027 (USD Million)
  23. Canada Antibodies Market, By Indication, From 2022 - 2027 (USD Million)
  24. Canada Antibodies Market, By End users, From 2022 - 2027 (USD Million)
  25. Canada Antibodies Market, By Application, From 2022 - 2027 (USD Million)
  26. North America Antibodies Market, By Monoclonal Antibodies, From 2022 - 2027 (USD Million)
  27. North America Murine Market, By Region, From 2022 - 2027 (USD Million)
  28. North America Chimeric Market, By Region, From 2022 - 2027 (USD Million)
  29. North America Humanized Market, By Region, From 2022 - 2027 (USD Million)
  30. North America Human Market, By Region, From 2022 - 2027 (USD Million)
  31. United States Antibodies Market, By Monoclonal Antibodies, From 2022 - 2027 (USD Million)
  32. Canada Antibodies Market, By Monoclonal Antibodies, From 2022 - 2027 (USD Million)
  33. North America Antibodies Market, By Polyclonal Antibodies, From 2022 - 2027 (USD Million)
  34. North America Type I Market, By Region, From 2022 - 2027 (USD Million)
  35. North America Type II Market, By Region, From 2022 - 2027 (USD Million)
  36. North America Type III Market, By Region, From 2022 - 2027 (USD Million)
  37. North America Type IV Market, By Region, From 2022 - 2027 (USD Million)
  38. North America Type V Market, By Region, From 2022 - 2027 (USD Million)
  39. North America Type VI Market, By Region, From 2022 - 2027 (USD Million)
  40. North America Type VII Market, By Region, From 2022 - 2027 (USD Million)
  41. North America Type VIII Market, By Region, From 2022 - 2027 (USD Million)
  42. United States Antibodies Market, By Polyclonal Antibodies, From 2022 - 2027 (USD Million)
  43. Canada Antibodies Market, By Polyclonal Antibodies, From 2022 - 2027 (USD Million)
  44. North America Antibodies Market, By Antibody-Drug Complexes, From 2022 - 2027 (USD Million)
  45. North America Immunogen Technology Market, By Region, From 2022 - 2027 (USD Million)
  46. North America Seattle Genetics Technology Market, By Region, From 2022 - 2027 (USD Million)
  47. North America Immunomedics technology Market, By Region, From 2022 - 2027 (USD Million)
  48. United States Antibodies Market, By Antibody-Drug Complexes, From 2022 - 2027 (USD Million)
  49. Canada Antibodies Market, By Antibody-Drug Complexes, From 2022 - 2027 (USD Million)
  50. North America Antibodies Market, By Experimental, From 2022 - 2027 (USD Million)
  51. North America Western Blot Market, By Region, From 2022 - 2027 (USD Million)
  52. North America ELISA Market, By Region, From 2022 - 2027 (USD Million)
  53. North America Radioimmune Assays Market, By Region, From 2022 - 2027 (USD Million)
  54. North America immunofluorescence Market, By Region, From 2022 - 2027 (USD Million)
  55. United States Antibodies Market, By Experimental, From 2022 - 2027 (USD Million)
  56. Canada Antibodies Market, By Experimental, From 2022 - 2027 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

PURCHASE OPTIONS

excel
$

3335


pdf excel
$

3680


pdf excel powerbi
$

5520


excel
$

2000

What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • 6 Months of Free Analyst Support.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • 1 Year of Free Analyst Support.
  • PDF, Excel and Power BI Dashboard.
  • Can be accessible by unlimited users.
  • 1 Year of Free Analyst Support.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.
customer-support
ASK FOR CUSTOMIZATION

Talk to our analyst and get customised report done according to your research needs

tag
INQUIRE FOR DISCOUNT

Check if you can avail any discount. Submit your details and our team will get back to you.

cloud-download
DOWNLOAD FREE SAMPLE

Request to avail a free sample report that reflects this market and its growth.

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 3335

Didn’t find what you’re looking for?
TALK TO OUR TEAM

Find it too expensive?
NO WORRIES!

Click for Request Sample